lymph node
Recently Published Documents


TOTAL DOCUMENTS

45667
(FIVE YEARS 11077)

H-INDEX

232
(FIVE YEARS 22)

2022 ◽  
Vol 27 ◽  
pp. 300584
Author(s):  
Hiroshi Harada ◽  
Takeharu Ono ◽  
Takanori Hirose ◽  
Hirohito Umeno ◽  
Jun Akiba ◽  
...  

2022 ◽  
Vol 272 ◽  
pp. 1-8
Author(s):  
Krystof Stanek ◽  
Filip Jonas ◽  
Pavla Ticha ◽  
Martin Molitor ◽  
Ondrej Mestak

2022 ◽  
Vol 270 ◽  
pp. 271-278
Author(s):  
Marcus Taylor ◽  
Matthew Evison ◽  
Bethan Clayton ◽  
Stuart W Grant ◽  
Glen P Martin ◽  
...  

2022 ◽  
Vol 32 (1) ◽  
pp. 19-36
Author(s):  
David Joyner ◽  
Tanvir Rizvi ◽  
Tuba Kalelioglu ◽  
Mark J. Jameson ◽  
Sugoto Mukherjee

2022 ◽  
Vol 11 ◽  
Author(s):  
Franco Picciotto ◽  
Adriana Lesca ◽  
Luca Mastorino ◽  
Elena Califaretti ◽  
Luca Conti ◽  
...  

Primary umbilical melanoma is rare tumor, representing about 5% of all umbilical malignancies.The lymphatic drainage from the tumor is challenging and can be to inguinal, axillary and retroperitoneal nodes. Dynamic and static lymphoscintigraphy with single-photon emission tomography/computed tomography (SPECT/CT) and sentinel lymph node biopsy (SLNB) is a widely validated technique in patients with clinically localized melanoma to search for and quantify nodal spread of cutaneous melanoma. Moreover, it offers the surgeon the preoperative information about the number and location of the sentinel lymph nodes (SLNs), which makes SLNB easier and quicker. This is the first report of an ulcerated thick melanoma of the umbilicus metastasizing only to an external iliac lymph-node without involvement of superficial inguinal SLNs. The preoperative high-resolution ultrasound (HR-US) examination of the regional lymph node field had been normal. This case-report shows how addition of SPECT/CT to planar imaging in a patient with clinically localized umbilical melanoma can help avoid incomplete SLNB when a deep SLN is not removed. A literature review of umbilical melanoma is also provided.


2022 ◽  
Vol 12 ◽  
Author(s):  
Liwei Jiang ◽  
Mine Yilmaz ◽  
Mayuko Uehara ◽  
Cecilia B. Cavazzoni ◽  
Vivek Kasinath ◽  
...  

Lymph node (LN)-resident stromal cells play an essential role in the proper functioning of LNs. The stromal compartment of the LN undergoes significant compensatory changes to produce a milieu amenable for regulation of the immune response. We have identified a distinct population of leptin receptor-expressing (LepR+) stromal cells, located in the vicinity of the high endothelial venules (HEVs) and lymphatics. These LepR+ stromal cells expressed markers for fibroblastic reticular cells (FRCs), but they lacked markers for follicular dendritic cells (FDCs) and marginal reticular cells (MRCs). Leptin signaling deficiency led to heightened inflammatory responses within the LNs of db/db mice, leakiness of HEVs, and lymphatic fragmentation. Leptin signaling through the JAK/STAT pathway supported LN stromal cell survival and promoted the anti-inflammatory properties of these cells. Conditional knockout of the LepR+ stromal cells in LNs resulted in HEV and extracellular matrix (ECM) abnormalities. Treatment of ob/ob mice with an agonist leptin fusion protein restored the microarchitecture of LNs, reduced intra-LN inflammatory responses, and corrected metabolic abnormalities. Future studies are needed to study the importance of LN stomal cell dysfunction to the pathogenesis of inflammatory responses in type 2 diabetes (T2D) in humans.


Biomedicines ◽  
2022 ◽  
Vol 10 (1) ◽  
pp. 179
Author(s):  
Young-Jae Ryu ◽  
Seong-Young Kwon ◽  
Soo-Young Lim ◽  
Yong-Min Na ◽  
Min-Ho Park

Skip lymph node (LN) metastases in papillary thyroid carcinoma (PTC) belong to N1b classification in the absence of central neck LN involvement. This study aimed to evaluate the predictive factors of skip metastases and their impact on recurrence in PTC patients with pN1b. A total of 334 PTC patients who underwent total thyroidectomy with LN dissection (central and lateral neck compartment) followed by radioactive iodine ablation were included. Patients with skip metastases tended to have a small primary tumor (≤1 cm) and single lateral neck level involvement. Tumor size ≤ 1 cm was an important predictive factor for skip metastases. Univariate analysis for recurrence showed that patients with a central LN ratio > 0.68, lateral LN ratio > 0.21, and stimulated thyroglobulin (Tg) levels > 7.3 ng/mL had shorter RFS (recurrence-free survival). The stimulated Tg level was associated with shorter RFS on multivariate analysis (>7.3 vs. ≤7.3 ng/mL; hazard ratio, 4.226; 95% confidence interval, 2.226−8.022; p < 0.001). Although patients with skip metastases tended to have a small primary tumor and lower burden of lateral neck LN involvement, there was no association between skip metastases and RFS in PTC with pN1b. Stimulated Tg level was a strong predictor of recurrence.


Sign in / Sign up

Export Citation Format

Share Document